Mongolia vs Uganda: Hepatitis B surface antigen (HBsAg) prevalence
Mongolia
0.3%
in 2024
Uganda
0.3%
in 2024
Mongolia rank
71st
Uganda rank
71st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Mongolia
- Uganda
How they compare
Mongolia currently reports 0.3% against 0.3% in Uganda, a difference of 0.0%.
The two have swapped places 4 times across 10 shared years of data; in 2015 it was Uganda ahead.
Mongolia ranks 71st and Uganda ranks 71st of 194 countries.
Across the 2 decades both report, Mongolia averaged higher in 1 and Uganda in 1.
Head to head by decade
| Decade | Mongolia | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.4% | 0.0% | Mongolia |
| 2020s | 0.3% | 0.4% | 0.0% | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Mongolia or Uganda?
- Mongolia, at 0.3% against 0.3% in Uganda as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Mongolia and Uganda?
- 0.0%, with Mongolia ahead.
- How many years of comparable data are there for Mongolia and Uganda?
- 10 years are reported by both, from 2015 to 2024.
- How do Mongolia and Uganda rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Mongolia ranks 71st and Uganda ranks 71st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.